![Erik Emerson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Emerson
Vorstandsvorsitzender bei
GLUCOTRACK, INC.
Vermögen: 256 211 $ am 30.06.2026
Profil
Erik Emerson was the founder of Symplmed Pharmaceuticals LLC, founded in 2013, serving as President & Chief Executive Officer from 2013 to 2018.
Current jobs include Chief Executive Officer & Director at GlucoTrack, Inc. starting in 2026, and Chief Executive & Director at Lokahi Therapeutics, Inc. starting in 2025.
Former jobs include Director at Adhera Therapeutics, Inc. in 2019; Marketing Director at Gilead Sciences, Inc. from 2007 to 2010; Senior Director-Commercial Development at XOMA Royalty Corp.
from 2010 to 2013; President & Director at Apimeds Pharmaceuticals US, Inc. from 2025 to 2026; Chief Commercial Officer at Mezzion Pharmaceuticals, Inc. from 2017 to 2020; and Chief Commercial Officer at Odyssey Health, Inc. from 2022 to 2023.
Education includes undergraduate studies at the University of Oregon.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GLUCOTRACK INC 9.45% | 17.07.2026 | 591’570 ( 9.45% ) | 188 711 $ | 30.06.2026 |
0.5% | 15.10.2025 | 75’000 ( 0.5% ) | 67 500 $ | 30.06.2026 |
Aktive Positionen von Erik Emerson
| Unternehmen | Position | Beginn |
|---|---|---|
| GLUCOTRACK, INC. | Vorstandsvorsitzender | 14.07.2026 |
Ehemalige bekannte Positionen von Erik Emerson
| Unternehmen | Position | Ende |
|---|---|---|
| ODYSSEY HEALTH, INC. | Corporate Officer/Principal | 01.10.2023 |
Mezzion Pharmaceuticals, Inc.
 Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Corporate Officer/Principal | 01.01.2020 |
| ADHERA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 19.12.2019 |
Symplmed Pharmaceuticals LLC
 Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | 01.05.2018 |
Ausbildung von Erik Emerson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
GlucoTrack, Inc.
 GlucoTrack, Inc. Medical SpecialtiesHealth Technology Develops a non-invasive glucose monitoring device | Health Technology |
Odyssey Health, Inc.
 Odyssey Health, Inc. Medical SpecialtiesHealth Technology Develops heart monitoring and screening devices | Health Technology |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adhera Therapeutics, Inc.
 Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
Symplmed Pharmaceuticals LLC
Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mezzion Pharmaceuticals, Inc.
Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Health Technology |
